Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Halliday

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Cell and Tissue Research|January 1, 1981
Early changes in concanavalin A-stimulated lymphocytes detected by the fluorescent probe N-phenyl-1-naphthylamineJ M Rolland, R L Betts, G M Halliday, et al.
Immunology|February 1, 1979
Rhodamine as a fluorescent probe of lymphocyte activationR C Nairn, I M Jablonka, J M Rolland, et al.
Neurobiology of Aging|May 27, 2005
Evidence for specific phases in the development of human neuromelaninH Fedorow, G M Halliday, C H Rickert, et al.
Journal of the Autonomic Nervous System|May 1, 1992
Rostrocaudal differences in morphology and neurotransmitter content of cells in the subretrofacial vasomotor nucleusJ W Polson, G M Halliday, R M McAllen, et al.
British Journal of Cancer|July 17, 1999
Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomasM A Lowes, G A Bishop, B E Cooke, et al.
Annals of Neurology|June 14, 2000
Regional brain atrophy in progressive supranuclear palsy and Lewy body diseaseN J Cordato, G M Halliday, A J Harding, et al.
Neurology|April 11, 2001
Cortical degeneration associated with phonologic and semantic language impairments in ADJ A Harasty, G M Halliday, J Xuereb, et al.
Journal of Immunological Methods|January 1, 1979
Detection of early lymphocyte activation by the fluorescent cell membrane probe N-phenyl-1-naphthylamineG M Halliday, R C Nairn, M A Pallett, et al.
The Journal of Investigative Dermatology|August 1, 1991
Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanomaF J Tefany, R S Barnetson, G M Halliday, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2007
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanomaP Hersey, G M Halliday, M L Farrelly, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Cell and Tissue Research|January 1, 1981
Early changes in concanavalin A-stimulated lymphocytes detected by the fluorescent probe N-phenyl-1-naphthylamineJ M Rolland, R L Betts, G M Halliday, et al.
Immunology|February 1, 1979
Rhodamine as a fluorescent probe of lymphocyte activationR C Nairn, I M Jablonka, J M Rolland, et al.
Neurobiology of Aging|May 27, 2005
Evidence for specific phases in the development of human neuromelaninH Fedorow, G M Halliday, C H Rickert, et al.
Journal of the Autonomic Nervous System|May 1, 1992
Rostrocaudal differences in morphology and neurotransmitter content of cells in the subretrofacial vasomotor nucleusJ W Polson, G M Halliday, R M McAllen, et al.
British Journal of Cancer|July 17, 1999
Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomasM A Lowes, G A Bishop, B E Cooke, et al.
Annals of Neurology|June 14, 2000
Regional brain atrophy in progressive supranuclear palsy and Lewy body diseaseN J Cordato, G M Halliday, A J Harding, et al.
Neurology|April 11, 2001
Cortical degeneration associated with phonologic and semantic language impairments in ADJ A Harasty, G M Halliday, J Xuereb, et al.
Journal of Immunological Methods|January 1, 1979
Detection of early lymphocyte activation by the fluorescent cell membrane probe N-phenyl-1-naphthylamineG M Halliday, R C Nairn, M A Pallett, et al.
The Journal of Investigative Dermatology|August 1, 1991
Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanomaF J Tefany, R S Barnetson, G M Halliday, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2007
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanomaP Hersey, G M Halliday, M L Farrelly, et al.
Pageof 24